Austria

Austria

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.76 (0.61 - 0.91) 2019 Modelled IHME
0.76 (0.62 - 0.89) 2018 Modelled IHME
0.76 (0.62 - 0.90) 2017 Modelled IHME
0.78 (0.64 - 0.91) 2016 Modelled IHME
0.8 (0.64 - 0.94) 2015 Modelled IHME
0.81 (0.66 - 0.95) 2014 Modelled IHME
0.82 (0.67 - 0.95) 2013 Modelled IHME
0.82 (0.68 - 0.95) 2012 Modelled IHME
0.83 (0.69 - 0.96) 2011 Modelled IHME
0.83 (0.69 - 0.97) 2010 Modelled IHME
0.84 (0.70 - 0.97) 2009 Modelled IHME
0.85 (0.71 - 0.99) 2008 Modelled IHME
0.87 (0.71 - 1) 2007 Modelled IHME
0.88 (0.72 - 1.02) 2006 Modelled IHME
0.89 (0.72 - 1.04) 2005 Modelled IHME
0.89 (0.73 - 1.04) 2004 Modelled IHME
0.9 (0.74 - 1.06) 2003 Modelled IHME
0.9 (0.75 - 1.07) 2002 Modelled IHME
0.91 (0.75 - 1.09) 2001 Modelled IHME
0.92 (0.75 - 1.10) 2000 Modelled IHME
0.92 (0.76 - 1.10) 1999 Modelled IHME
0.93 (0.75 - 1.11) 1998 Modelled IHME
0.93 (0.76 - 1.11) 1997 Modelled IHME
0.94 (0.76 - 1.11) 1996 Modelled IHME
0.94 (0.76 - 1.12) 1995 Modelled IHME
0.95 (0.77 - 1.12) 1994 Modelled IHME
0.95 (0.77 - 1.12) 1993 Modelled IHME
0.95 (0.77 - 1.12) 1992 Modelled IHME
0.96 (0.78 - 1.13) 1991 Modelled IHME
0.96 (0.77 - 1.14) 1990 Modelled IHME
1.03 (0.51 - 1.89) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.06 (0.04 - 0.08) 2019 Modelled IHME
0.06 (0.04 - 0.08) 2018 Modelled IHME
0.05 (0.04 - 0.07) 2017 Modelled IHME
0.05 (0.03 - 0.06) 2016 Modelled IHME
0.04 (0.03 - 0.06) 2015 Modelled IHME
0.05 (0.03 - 0.06) 2014 Modelled IHME
0.05 (0.03 - 0.07) 2013 Modelled IHME
0.06 (0.04 - 0.08) 2012 Modelled IHME
0.07 (0.04 - 0.09) 2011 Modelled IHME
0.07 (0.04 - 0.10) 2010 Modelled IHME
0.07 (0.04 - 0.10) 2009 Modelled IHME
0.07 (0.05 - 0.10) 2008 Modelled IHME
0.08 (0.05 - 0.10) 2007 Modelled IHME
0.08 (0.05 - 0.10) 2006 Modelled IHME
0.08 (0.05 - 0.11) 2005 Modelled IHME
0.1 (0.06 - 0.12) 2004 Modelled IHME
0.13 (0.08 - 0.17) 2003 Modelled IHME
0.17 (0.10 - 0.23) 2002 Modelled IHME
0.21 (0.13 - 0.29) 2001 Modelled IHME
0.25 (0.15 - 0.35) 2000 Modelled IHME
0.29 (0.18 - 0.40) 1999 Modelled IHME
0.33 (0.21 - 0.46) 1998 Modelled IHME
0.37 (0.24 - 0.52) 1997 Modelled IHME
0.4 (0.27 - 0.57) 1996 Modelled IHME
0.42 (0.28 - 0.60) 1995 Modelled IHME
0.42 (0.28 - 0.59) 1994 Modelled IHME
0.42 (0.28 - 0.59) 1993 Modelled IHME
0.42 (0.28 - 0.59) 1992 Modelled IHME
0.42 (0.28 - 0.59) 1991 Modelled IHME
0.42 (0.28 - 0.59) 1990 Modelled IHME
0.32 (0.15 - 0.62) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
74,561 (60,025 - 88,442) 1990 Modelled IHME
74,582 (60,493 - 87,757) 1991 Modelled IHME
74,568 (60,484 - 87,619) 1992 Modelled IHME
74,529 (60,500 - 87,613) 1993 Modelled IHME
74,461 (60,537 - 87,816) 1994 Modelled IHME
74,374 (60,348 - 88,427) 1995 Modelled IHME
74,250 (60,529 - 88,164) 1996 Modelled IHME
74,068 (60,223 - 88,179) 1997 Modelled IHME
73,845 (60,143 - 88,383) 1998 Modelled IHME
73,621 (60,366 - 88,159) 1999 Modelled IHME
73,436 (60,039 - 88,237) 2000 Modelled IHME
73,304 (60,219 - 87,388) 2001 Modelled IHME
73,219 (60,524 - 86,325) 2002 Modelled IHME
73,152 (60,314 - 85,952) 2003 Modelled IHME
73,077 (59,864 - 85,544) 2004 Modelled IHME
72,928 (59,427 - 85,373) 2005 Modelled IHME
72,542 (59,481 - 84,100) 2006 Modelled IHME
71,918 (59,292 - 82,923) 2007 Modelled IHME
71,178 (59,168 - 82,338) 2008 Modelled IHME
70,445 (58,732 - 81,399) 2009 Modelled IHME
69,882 (57,965 - 81,073) 2010 Modelled IHME
69,583 (57,988 - 80,449) 2011 Modelled IHME
69,494 (57,610 - 80,411) 2012 Modelled IHME
69,523 (57,073 - 80,633) 2013 Modelled IHME
69,564 (56,559 - 81,120) 2014 Modelled IHME
69,466 (55,790 - 81,593) 2015 Modelled IHME
68,168 (55,575 - 79,782) 2016 Modelled IHME
67,020 (54,291 - 79,260) 2017 Modelled IHME
67,206 (55,038 - 79,066) 2018 Modelled IHME
67,527 (54,458 - 80,815) 2019 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.87 (1.39 - 2.44) 2019 Modelled IHME
1.88 (1.40 - 2.45) 2018 Modelled IHME
1.9 (1.41 - 2.46) 2017 Modelled IHME
1.94 (1.45 - 2.53) 2016 Modelled IHME
2 (1.48 - 2.63) 2015 Modelled IHME
2.05 (1.52 - 2.68) 2014 Modelled IHME
2.17 (1.60 - 2.84) 2013 Modelled IHME
2.31 (1.71 - 3.03) 2012 Modelled IHME
2.44 (1.80 - 3.22) 2011 Modelled IHME
2.6 (1.91 - 3.43) 2010 Modelled IHME
2.75 (2.02 - 3.64) 2009 Modelled IHME
2.85 (2.12 - 3.75) 2008 Modelled IHME
3.03 (2.25 - 3.96) 2007 Modelled IHME
3.17 (2.36 - 4.15) 2006 Modelled IHME
3.32 (2.48 - 4.34) 2005 Modelled IHME
3.38 (2.53 - 4.45) 2004 Modelled IHME
3.44 (2.56 - 4.52) 2003 Modelled IHME
3.37 (2.51 - 4.44) 2002 Modelled IHME
3.29 (2.42 - 4.34) 2001 Modelled IHME
3.28 (2.44 - 4.33) 2000 Modelled IHME
3.28 (2.43 - 4.34) 1999 Modelled IHME
3.33 (2.45 - 4.39) 1998 Modelled IHME
3.36 (2.45 - 4.45) 1997 Modelled IHME
3.44 (2.52 - 4.56) 1996 Modelled IHME
3.48 (2.52 - 4.62) 1995 Modelled IHME
3.5 (2.54 - 4.68) 1994 Modelled IHME
3.55 (2.58 - 4.73) 1993 Modelled IHME
3.57 (2.59 - 4.76) 1992 Modelled IHME
3.57 (2.59 - 4.73) 1991 Modelled IHME
3.51 (2.56 - 4.65) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
167 (124 - 218) 2019 Modelled IHME
166 (124 - 217) 2018 Modelled IHME
167 (125 - 216) 2017 Modelled IHME
169 (126 - 221) 2016 Modelled IHME
173 (128 - 228) 2015 Modelled IHME
176 (131 - 230) 2014 Modelled IHME
184 (136 - 242) 2013 Modelled IHME
195 (145 - 256) 2012 Modelled IHME
205 (152 - 270) 2011 Modelled IHME
217 (160 - 287) 2010 Modelled IHME
229 (169 - 304) 2009 Modelled IHME
237 (177 - 313) 2008 Modelled IHME
252 (187 - 329) 2007 Modelled IHME
262 (196 - 343) 2006 Modelled IHME
274 (205 - 358) 2005 Modelled IHME
277 (207 - 364) 2004 Modelled IHME
280 (208 - 368) 2003 Modelled IHME
273 (203 - 359) 2002 Modelled IHME
265 (195 - 350) 2001 Modelled IHME
263 (195 - 348) 2000 Modelled IHME
262 (194 - 347) 1999 Modelled IHME
265 (195 - 350) 1998 Modelled IHME
267 (195 - 353) 1997 Modelled IHME
273 (199 - 361) 1996 Modelled IHME
275 (199 - 365) 1995 Modelled IHME
276 (200 - 369) 1994 Modelled IHME
279 (203 - 371) 1993 Modelled IHME
280 (203 - 372) 1992 Modelled IHME
278 (202 - 368) 1991 Modelled IHME
273 (199 - 361) 1990 Modelled IHME
503 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
6 (4 - 9) 2019 Modelled IHME
6 (4 - 9) 2018 Modelled IHME
6 (4 - 9) 2017 Modelled IHME
6 (4 - 9) 2016 Modelled IHME
6 (4 - 9) 2015 Modelled IHME
6 (4 - 9) 2014 Modelled IHME
6 (4 - 9) 2013 Modelled IHME
6 (4 - 9) 2012 Modelled IHME
6 (4 - 10) 2011 Modelled IHME
7 (4 - 10) 2010 Modelled IHME
7 (4 - 10) 2009 Modelled IHME
7 (4 - 10) 2008 Modelled IHME
7 (5 - 10) 2007 Modelled IHME
7 (5 - 10) 2006 Modelled IHME
7 (5 - 10) 2005 Modelled IHME
7 (5 - 10) 2004 Modelled IHME
7 (5 - 10) 2003 Modelled IHME
7 (5 - 10) 2002 Modelled IHME
7 (5 - 11) 2001 Modelled IHME
7 (5 - 11) 2000 Modelled IHME
7 (5 - 11) 1999 Modelled IHME
7 (5 - 11) 1998 Modelled IHME
7 (5 - 11) 1997 Modelled IHME
7 (5 - 11) 1996 Modelled IHME
7 (5 - 11) 1995 Modelled IHME
7 (5 - 11) 1994 Modelled IHME
7 (5 - 11) 1993 Modelled IHME
7 (5 - 11) 1992 Modelled IHME
7 (5 - 11) 1991 Modelled IHME
7 (5 - 11) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
85 2018 Survey/reported WHO/UNICEF
90 2017 Survey/reported WHO/UNICEF
87 2016 Survey/reported WHO/UNICEF
93 2015 Survey/reported WHO/UNICEF
98 2014 Survey/reported WHO/UNICEF
95 2013 Survey/reported WHO/UNICEF
92 2012 Survey/reported WHO/UNICEF
89 2011 Survey/reported WHO/UNICEF
86 2010 Survey/reported WHO/UNICEF
83 2009 Survey/reported WHO/UNICEF
83 2008 Survey/reported WHO/UNICEF
85 2007 Survey/reported WHO/UNICEF
83 2006 Survey/reported WHO/UNICEF
86 2005 Survey/reported WHO/UNICEF
83 2004 Survey/reported WHO/UNICEF
83 2003 Survey/reported WHO/UNICEF
81 2002 Survey/reported WHO/UNICEF
44 2001 Survey/reported WHO/UNICEF
33 2000 Survey/reported WHO/UNICEF
85 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
321 (244 - 468) 2015 Survey/reported EMCDDA, 2017
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
50 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HBV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.93 (0.76 - 1.13) 2019 Modelled IHME
0.92 (0.76 - 1.12) 2018 Modelled IHME
0.92 (0.75 - 1.12) 2017 Modelled IHME
0.91 (0.75 - 1.11) 2016 Modelled IHME
0.91 (0.74 - 1.12) 2015 Modelled IHME
0.91 (0.74 - 1.12) 2014 Modelled IHME
0.91 (0.75 - 1.12) 2013 Modelled IHME
0.91 (0.75 - 1.12) 2012 Modelled IHME
0.92 (0.76 - 1.12) 2011 Modelled IHME
0.92 (0.76 - 1.13) 2010 Modelled IHME
0.92 (0.76 - 1.12) 2009 Modelled IHME
0.92 (0.76 - 1.12) 2008 Modelled IHME
0.92 (0.76 - 1.11) 2007 Modelled IHME
0.92 (0.75 - 1.10) 2006 Modelled IHME
0.92 (0.75 - 1.10) 2005 Modelled IHME
0.91 (0.75 - 1.10) 2004 Modelled IHME
0.91 (0.75 - 1.10) 2003 Modelled IHME
0.91 (0.75 - 1.09) 2002 Modelled IHME
0.91 (0.75 - 1.09) 2001 Modelled IHME
0.91 (0.74 - 1.10) 2000 Modelled IHME
0.91 (0.74 - 1.09) 1999 Modelled IHME
0.9 (0.74 - 1.09) 1998 Modelled IHME
0.9 (0.74 - 1.08) 1997 Modelled IHME
0.9 (0.74 - 1.08) 1996 Modelled IHME
0.9 (0.74 - 1.08) 1995 Modelled IHME
0.9 (0.74 - 1.07) 1994 Modelled IHME
0.89 (0.74 - 1.07) 1993 Modelled IHME
0.89 (0.74 - 1.08) 1992 Modelled IHME
0.89 (0.73 - 1.08) 1991 Modelled IHME
0.89 (0.73 - 1.08) 1990 Modelled IHME
0.2 (0.10 - 0.40) 2015 Modelled Blach et al, 2017
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.5 (0.10 - 0.70) 2014 Modelled Gower et al, 2014
People who inject drugs (PWID)
Download
Value (%) Year Type Source
31.3 (18.70 - 46.30) 2013 Survey/reported EMCDDA
60.9 (54.80 - 67) 2012 Modelled Degenhardt L et al, 2017
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
68,876 (56,429 - 83,947) 1990 Modelled IHME
69,307 (57,100 - 84,163) 1991 Modelled IHME
69,730 (57,795 - 84,112) 1992 Modelled IHME
70,140 (58,042 - 84,366) 1993 Modelled IHME
70,521 (58,366 - 84,536) 1994 Modelled IHME
70,870 (58,291 - 84,900) 1995 Modelled IHME
71,221 (58,799 - 85,208) 1996 Modelled IHME
71,590 (59,118 - 85,659) 1997 Modelled IHME
71,963 (59,233 - 86,500) 1998 Modelled IHME
72,342 (59,203 - 87,102) 1999 Modelled IHME
72,735 (59,581 - 87,854) 2000 Modelled IHME
73,175 (60,032 - 88,150) 2001 Modelled IHME
73,701 (60,388 - 88,294) 2002 Modelled IHME
74,272 (60,792 - 89,279) 2003 Modelled IHME
74,859 (61,171 - 90,026) 2004 Modelled IHME
75,384 (61,478 - 90,749) 2005 Modelled IHME
75,799 (62,115 - 91,347) 2006 Modelled IHME
76,147 (62,774 - 92,507) 2007 Modelled IHME
76,435 (63,045 - 93,324) 2008 Modelled IHME
76,668 (63,268 - 93,896) 2009 Modelled IHME
76,896 (63,487 - 94,699) 2010 Modelled IHME
77,069 (63,547 - 94,438) 2011 Modelled IHME
77,198 (63,683 - 94,825) 2012 Modelled IHME
77,403 (63,671 - 95,237) 2013 Modelled IHME
77,787 (63,677 - 96,037) 2014 Modelled IHME
78,414 (64,024 - 96,837) 2015 Modelled IHME
79,452 (65,473 - 97,097) 2016 Modelled IHME
80,591 (66,121 - 98,257) 2017 Modelled IHME
81,652 (67,198 - 99,030) 2018 Modelled IHME
82,746 (67,850 - 100,439) 2019 Modelled IHME
21,000 (6,000 - 30,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
6.25 (4.86 - 7.74) 2019 Modelled IHME
6.26 (4.91 - 7.76) 2018 Modelled IHME
6.35 (5.02 - 7.85) 2017 Modelled IHME
6.44 (5.09 - 7.97) 2016 Modelled IHME
6.63 (5.26 - 8.27) 2015 Modelled IHME
6.66 (5.29 - 8.29) 2014 Modelled IHME
6.73 (5.34 - 8.35) 2013 Modelled IHME
6.74 (5.38 - 8.39) 2012 Modelled IHME
6.65 (5.33 - 8.31) 2011 Modelled IHME
6.67 (5.34 - 8.33) 2010 Modelled IHME
6.65 (5.34 - 8.34) 2009 Modelled IHME
6.48 (5.17 - 8.12) 2008 Modelled IHME
6.49 (5.18 - 8.12) 2007 Modelled IHME
6.49 (5.18 - 8.14) 2006 Modelled IHME
6.6 (5.25 - 8.33) 2005 Modelled IHME
6.63 (5.28 - 8.43) 2004 Modelled IHME
6.66 (5.29 - 8.44) 2003 Modelled IHME
6.49 (5.14 - 8.20) 2002 Modelled IHME
6.26 (4.97 - 7.89) 2001 Modelled IHME
6.19 (4.88 - 7.83) 2000 Modelled IHME
6.13 (4.85 - 7.72) 1999 Modelled IHME
6.15 (4.84 - 7.79) 1998 Modelled IHME
6.18 (4.86 - 7.90) 1997 Modelled IHME
6.25 (4.89 - 8) 1996 Modelled IHME
6.27 (4.89 - 8.08) 1995 Modelled IHME
6.27 (4.89 - 8.10) 1994 Modelled IHME
6.33 (4.94 - 8.16) 1993 Modelled IHME
6.39 (4.99 - 8.20) 1992 Modelled IHME
6.4 (4.99 - 8.26) 1991 Modelled IHME
6.31 (4.92 - 8.19) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
558 (433 - 690) 2019 Modelled IHME
555 (435 - 687) 2018 Modelled IHME
559 (442 - 691) 2017 Modelled IHME
563 (445 - 696) 2016 Modelled IHME
575 (455 - 716) 2015 Modelled IHME
571 (454 - 711) 2014 Modelled IHME
572 (455 - 710) 2013 Modelled IHME
569 (454 - 708) 2012 Modelled IHME
559 (448 - 698) 2011 Modelled IHME
559 (447 - 697) 2010 Modelled IHME
555 (446 - 696) 2009 Modelled IHME
540 (431 - 676) 2008 Modelled IHME
539 (430 - 674) 2007 Modelled IHME
537 (429 - 674) 2006 Modelled IHME
543 (433 - 686) 2005 Modelled IHME
543 (432 - 690) 2004 Modelled IHME
542 (431 - 687) 2003 Modelled IHME
525 (416 - 663) 2002 Modelled IHME
504 (400 - 635) 2001 Modelled IHME
496 (392 - 628) 2000 Modelled IHME
490 (388 - 617) 1999 Modelled IHME
490 (386 - 620) 1998 Modelled IHME
491 (386 - 627) 1997 Modelled IHME
495 (387 - 634) 1996 Modelled IHME
495 (386 - 638) 1995 Modelled IHME
494 (385 - 638) 1994 Modelled IHME
497 (388 - 640) 1993 Modelled IHME
500 (390 - 642) 1992 Modelled IHME
499 (389 - 644) 1991 Modelled IHME
490 (382 - 636) 1990 Modelled IHME
588 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
32 (23 - 42) 2019 Modelled IHME
32 (24 - 42) 2018 Modelled IHME
32 (23 - 42) 2017 Modelled IHME
32 (23 - 41) 2016 Modelled IHME
32 (23 - 41) 2015 Modelled IHME
32 (23 - 41) 2014 Modelled IHME
32 (23 - 41) 2013 Modelled IHME
32 (23 - 41) 2012 Modelled IHME
32 (23 - 41) 2011 Modelled IHME
32 (24 - 41) 2010 Modelled IHME
32 (24 - 41) 2009 Modelled IHME
32 (24 - 41) 2008 Modelled IHME
32 (24 - 41) 2007 Modelled IHME
32 (24 - 42) 2006 Modelled IHME
32 (24 - 42) 2005 Modelled IHME
32 (24 - 41) 2004 Modelled IHME
32 (24 - 41) 2003 Modelled IHME
32 (24 - 41) 2002 Modelled IHME
31 (23 - 40) 2001 Modelled IHME
31 (23 - 40) 2000 Modelled IHME
31 (23 - 40) 1999 Modelled IHME
31 (23 - 39) 1998 Modelled IHME
31 (23 - 39) 1997 Modelled IHME
30 (22 - 39) 1996 Modelled IHME
31 (22 - 39) 1995 Modelled IHME
31 (22 - 39) 1994 Modelled IHME
31 (22 - 39) 1993 Modelled IHME
31 (23 - 40) 1992 Modelled IHME
31 (23 - 40) 1991 Modelled IHME
31 (23 - 41) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
321 (244 - 468) 2015 Survey/reported EMCDDA, 2017
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
50 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HBV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
167
2019
(124 - 218)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
558
2019
(433 - 690)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
321
2015
(244 - 468)
EMCDDA, 2017
Eligible for HBV generic medicines
Eligible for HCV generic medicines